122 results
Page 3 of 7
8-K
EX-99.1
ds5 co1s2nezbfr9oz
30 Mar 22
Agile Therapeutics Reports Fourth Quarter & Full Year 2021 Financial Results and Provides Corporate Update
4:19pm
424B5
7l909o47i9rm94 bmvo
14 Mar 22
Prospectus supplement for primary offering
5:26pm
8-K
80grz9 ddm7l7yd
10 Jan 22
Entry into a Material Definitive Agreement
8:05am
424B5
0ufmzl49h zqu
10 Jan 22
Prospectus supplement for primary offering
8:00am
8-K
EX-99.1
4arp0xc8 r0tqkbqy
2 Nov 21
Agile Therapeutics Reports Third Quarter 2021 Financial Results
4:11pm
424B5
fomkfq7rjedyh41uv
8 Oct 21
Prospectus supplement for primary offering
5:21pm
424B5
hp0x 0e2tqn0vvrfxzge
7 Oct 21
Prospectus supplement for primary offering
5:24pm
8-K
EX-99.1
bx6xvx
26 Jul 21
Agile Therapeutics Reports Second Quarter 2021 Financial Results
4:10pm
8-K
EX-99.1
448gl
4 May 21
Agile Therapeutics Reports First Quarter 2021 Financial Results
4:10pm
424B5
ec7 scxs5r64x42
18 Mar 21
Prospectus supplement for primary offering
5:01pm
8-K
EX-99.1
ddxr fbv3x
1 Mar 21
Results of Operations and Financial Condition
4:10pm
8-K
EX-99.1
dhalh ic92nisv63g
12 Nov 20
Agile Therapeutics Reports Third Quarter 2020 Financial Results
4:10pm
8-K
EX-10.2
k0izbzqfolz01irsrls
17 Aug 20
Departure of Directors or Certain Officers
4:30pm